SLAM Orthopedic winner Investors Forum Prize

SLAM Orthopedic winner Investors Forum Prize

May 31, 2022

During the Investors Forum ten young companies had the opportunity to present their company to interesting partners and discuss their business strategy, technology direction and capital-raising plan.  On stage of the 17th edition of the Dutch Life Sciences Conference, SLAM Orthopedic became the proud winner of the Investors Forum Prize and was awarded a partnering ticket, national or international, with a total value of €2,500.

Expert Class Human Resources for today's Life Sciences companies

Expert Class Human Resources for today's Life Sciences companies

May 30, 2022

To succeed in the Biotechnology industry, human resources must be a true business partner. However, many starting and young companies still either do not have HR representation, or add these responsibilities to the busy schedule of an administrative assistant or finance officer.  Usually the question is “can we afford to hire an HR representative”.

The Winner of the Venture Challenge Fall 2021 is QurieGen!

The Winner of the Venture Challenge Fall 2021 is QurieGen!

May 23, 2022

Due to Covid, last year’s winners of the Venture Challenge were announced today at the Dutch Life Sciences Conference. The proud winner of the fall edition is QurieGen, formerly known as Monoceros Analytics. The innovative startup QurieGen has developed a single-cell sequencing-based method to map the changes in transcriptome, membrane and 100’ of intracellular (phospho)proteins simultaneously across multiple pathways (IP filed) to obtain a high-resolution map of cellular response.

Expert Class Life Sciences business- and sales development

Expert Class Life Sciences business- and sales development

February 16, 2022

A solid business development strategy is crucial for the development of life sciences products and companies. For young companies it provides funding for research and product development whereas for larger companies it manage their (IP) portfolios, adjusting risks, revenue streams and company strategy.

Stay up to date with the latest news!

Newsletter subscribe